全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Marisa T Patriarca , Geraldo Rodrigues de Lima , João N Stavale ...
来源:[J].European Journal of Obstetrics and Gynecology(IF 1.843), 2001, Vol.98 (1), pp.119-123
摘要:... Methods : A total of 30 postmenopausal women were treated with unopposed estrogen for 21 days each month followed by a regular pause of 9–10 days, and were studied prospectively for 18 months. The TVS measurements of endometrial thickness and biopsy of the endometrium we...
作者:Tammy S. Shields , Noel S. Weiss , Lynda F. Voigt ...
来源:[J].Epidemiology(IF 5.738), 1999, Vol.10 (6), pp.733-738
摘要:... Our goal was to identify a subgroup of women in whom the additional cancer risk associated with unopposed estrogen use was sufficiently small so as to not be a deterrent to taking a hormone preparation of this type. Researchers interviewed women with endometrial cancer (N =...
作者:Teras , Patel , Hildebrand ...
来源:[J].Leukemia & Lymphoma(IF 2.301), 2013, Vol.54 (4), pp.720-725
摘要:... Using extended Cox regression, we observed a statistically significant 29% higher risk of NHL for ever unopposed estrogen use compared to never use, which was restricted to follicular lymphoma (current estrogen compared to never use, hazard ratio [HR] = 2.25, 95% confidence ...
作者:Liudmila Husak , Viola Vaccarino , Emir Veledar ...
来源:[J].The American Journal of Cardiology(IF 3.209), 2003, Vol.93 (5), pp.563-568
摘要:... Although recent experimental studies have revealed no beneficial effect of combination therapy with estrogen (E) and progesterone (P), the effect of monotherapy with E remains unknown. We retrospectively examined the medical records of 843 consecutive women aged ≥55 years ...
作者:Martha S. Linet
来源:[J].American Journal of Epidemiology(IF 4.78), 2008, Vol.167 (12), pp.1416-1420
摘要:...s Health Initiative (WHI) compare breast cancer findings from the randomized trial of unopposed estrogen with those from the large WHI observational study. This commentary briefly summarizes historical highlights of menopausal hormone use; risk-versus-benefit evaluations; scie...
作者:Gaia Pocobelli , Polly A. Newcomb , Christopher I. Li ...
来源:[J].Breast Cancer Research and Treatment(IF 4.469), 2014, Vol.145 (2), pp.439-447
摘要:... We evaluated fatal breast cancer risk in relation to recency and duration of use of CHT and unopposed estrogen hormone therapy (EHT). A total of 1,288 cases and 12,535 controls were included in the analyses. Exclusive use of EHT was not associated with fatal breast cancer ri...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×